The plethora of mechanisms by which MDSCs block both antigen-specific and non-antigen specific T-cell anti-tumor response include: (a) secretion of immune suppressive cytokines such as TGF-β and IL-10, (b) deprivation of metabolites essential for immune cell fitness and function such as L arginine and L-cysteine, (c) T-cell migration impairment, (d) interference with TCR structure and function throughout production of reactive oxygen species (ROS), and (e) CD4 T cells’ conversion toward regulatory suppressive phenotype [175]. This evidence concerns the gene TGFB1 and neoplasm.